The Department of Health, of which the TGA is a part, is required by section 11C of the Freedom of Information Act 1982 (the FOI Act) to disclose access decisions through a disclosure log on its website. The disclosure log provides access to information which has been released in response to an FOI request. However, personal information and information about the business, commercial, financial or professional affairs of a person is deleted from the documents if publication of that information would be unreasonable.
The documents released by the TGA under section 11C of the FOI Act have been made available on this site in Portable Document Format (PDF). They are available for downloading and printing. If you require access to the documents in an alternative format please contact the FOI Coordinator by emailing tga.foi@health.gov.au or calling the TGA on 1800 020 653 or 02 6289 4630.
For documents released under the FOI Act by the Department of Health, please visit the Department of Health's FOI disclosure log.
| Date of release | FOI number | Documents |
|---|---|---|
| 17 June 2021 | FOI 2183 | Clinical trial results relating to the Pfizer and AstraZeneca COVID-19 vaccines
|
| 2 June 2021 | FOI 2289 | Safety data relating to the Pfizer COVID-19 vaccine including pregnancy categorisation |
| 28 May 2021 | FOI 2260 | Minutes from the Meeting of the Advisory Committee on Medicines Scheduling concerning the interim decision of 3 February 2021 on the amendment of the current Poisons Standard in relation to psilocybin and MDMA. |
| 18 May 2021 | FOI 2370 | Request for documents relating to SAS category B applications during the period of 01/01/2019 to 30/04/2021 inclusive for medicinal cannabis |
| 14 April 2021 | FOI 2250 | Request for documents relating to SAS B approvals for medicinal cannabis product |
| 1 April 2021 | FOI 2275 | Special Access Scheme Category B pathway specific to medicinal cannabis products during the period 1/11/2016 to 1/03/2020 |
| 25 March 2021 | FOI 2199 | Request for public ARTG summary document for therapeutic goods containing or consisting of Sitagliptin. |
| 26 February 2021 | FOI 2189 | Internal TGA policies and procedures relating to TGA complaint handling processes. |
| 11 February 2021 | FOI 2184 | Request for spreadsheet of Special Access Scheme applications for medical cannabis for period 1 August 2020 to 16 January 2021 |
| 4 February 2021 | FOI 2075 | Documents showing the dates of approval of new indications for Risperdal (Risperidone) film coated tablets. |
| 27 January 2021 | FOI 2191 | The sponsor of the Birmingham Hip Resurfacing Device |
| 25 January 2021 | FOI 2076 | Request for documents relating to shortages of anti-seizure medications (list provided) from the TGA's Medicine Shortages Information Initiative |
| 3 December 2020 | FOI 2014 | Country of Origin where Paraosteo 665 is made. |
| 3 December 2020 | FOI 2066 | Request for documents relating to Ostelin Specialist Range Vitamin D 7000IU |
| 25 November 2020 | FOI 1986 | Approved use of Ethicon UltraPro Hernia Mesh |
| 16 November 2020 | FOI 1866 | Request for documents relating to the LARS ligament for anterior cruciate ligament injuries |
| 12 November 2020 | FOI 1807 | Request for documents relating to the decision made in December 2016 to up-schedule codeine
|
| 9 November 2020 | FOI 1985 | Medicinal cannabis advertising compliance complaints |
| 2 November 2020 | FOI 2013 | SAS Category B applications for medicinal cannabis - 1/11/16-30/09/20 |
| 2 November 2020 | FOI 1871 | TGA position on hydroxychloroquine |
| 29 September 2020 | FOI 959 | Request for details of approvals to supply Thrombin under the Special Access Scheme between January 2019 to December 2019 |
| 1 September 2020 | FOI 1845 | Request for documents relating to Authorised Prescribers of medicinal cannabis |
| 21 August 2020 | FOI 1785 | Advisory Committee on Vaccines - Members Declarations of Interest
|
| 7 August 2020 | FOI 1814 | Request for a copy of the evaluation Report for POLYGLYCERYL-6 POLYRICINOLEATE |
| 27 July 2020 | FOI 1802 | Request for copies of the two earliest Special Access Application forms for specified dates for the use of Humira adalimumab for the treatment of patients with inflammatory bowel disease and their approvals |
| 23 July 2020 | FOI 1789 | Request for copies of the two earliest Special Access Application forms for various date ranges for the use of Humira adalimumab for treating patients with psoriatic arthritis |
| 22 July 2020 | FOI 1782 | Request for Special Access Scheme notifications/ approvals for adalimumab (Humira) between 2002-2006 |
| 21 July 2020 | FOI 1741 | Request for documents relating to adverse event reports for medicinal cannabis products |
| 17 July 2020 | FOI 1799 | Request for details about medicinal cannabis applications through SAS from 1 December 2019 - 24 June 2020 |
| 1 Jul 2019 to 30 Jun 2020 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2019 to Jun 2020 | |
| 1 Jul 2018 to 30 Jun 2019 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2018 to Jun 2019 | |
| 1 Jul 2017 to 30 Jun 2018 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2017 to Jun 2018 | |
| 1 Jul 2016 to 30 Jun 2017 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2016 to Jun 2017 | |
| 1 Jul 2015 to 30 Jun 2016 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2015 to Jun 2016 | |
| 1 Jul 2014 to 30 Jun 2015 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2014 to Jun 2015 | |
| 1 Jul 2013 to 30 Jun 2014 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2013 to Jun 2014 | |
| 1 Jul 2012 to 30 Jun 2013 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2012 to Jun 2013 | |
| 1 Jul 2011 to 30 Jun 2012 | Documents released under Section 11C of the Freedom of Information Act 1982, Jul 2011 to Jun 2012 | |